SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
85.20    1.20 (1.43%)
Bid:
85.20
Ask:
85.90
Spread: 0.70 (0.822%)
Market Cap: £238.73m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Trading Update

17 Sep 2024 07:00

RNS Number : 4109E
Essentra plc
17 September 2024
 

This announcement contains inside information (as defined by Article 7 of Regulation (EU) No 596/2014), as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

ESSENTRA PLC

("Essentra", the "Group" or the "Company")

 

TRADING UPDATE

 

Essentra plc, a leading global manufacturer, and provider of essential components and solutions, provides the following trading update in respect of the current financial year ending 31 December 2024.

At the half year results, published 30 July 2024, the Group indicated that market conditions in its end-markets were mixed by region, with modest sequential improvement in volume trends through the first half. The Group had previously anticipated a further modest improvement in volumes in the second half, underpinned by ongoing recovery of demand across end-markets. However, through August and into September, consistent with the weak PMI metrics widely reported, market conditions in Europe, (including Turkey) have softened. Whilst the Americas region has reported a slower than anticipated rate of recovery, APAC remains broadly in line with expectations.

The impact of the market back drop on trading since the half year 2024 results, combined with a consequently more cautious view of the likely timing of further modest improvements in market conditions has led to the Board revising its expectations for full year 2024. Including the impact of adverse foreign exchange retranslation, estimated to be c.£2m, the Board now expects 2024 full year adjusted1 operating profit to be in the range of £40m-£42m2.

Management remain confident in the business model and that the Company is well positioned, supported by a right-sized cost base and robust operations, to benefit from high levels of operational leverage when normalised growth returns. The Group continues to balance its investment in value creating opportunities across the business alongside cost mitigation activities and driving efficiencies, which has supported strong gross and operating margins. The balance sheet remains robust, and full year leverage guidance remains unchanged.

Essentra will issue its Q3 results for the three months ending 28 September 2024 on 24 October 2024.

Enquiries

Essentra plc

Jack Clarke, Chief Financial Officer

Claire Goodman, Head of Investor Relations

Emma Reid, Company Secretary

Tel: +44 (0)1908 359100

FTI Consulting

Richard Mountain

Ariadna Peretz

FTI_essentra@fticonsulting.com

Tel: +44 (0)20 3727 1340

 

The person responsible for release of this announcement is Emma Reid, Company Secretary.

 

1. On a continuing operations basis, before amortisation of acquired intangible assets and adjusting items

2. Company compiled market expectations for 2024 adjusted operating profit are currently between £48.4m and £49.7m

 

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes c.3,000 employees, 14 manufacturing facilities, 24 distribution centres and 33 sales & service centres serving c.69,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy. For further information, please visit www.essentraplc.com

LEI: 5493007MOZNA03BVNE96

Cautionary forward-looking statement

These results contain forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. The Company accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events of developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIGDCDSBDGSL
Date   Source Headline
23rd Oct 201910:35 amRNSHolding(s) in Company
1st Oct 20198:21 amRNSTotal Voting Rights
9th Sep 20197:00 amRNSAcquisition of Nekicesa Packaging S.L.
3rd Sep 20193:45 pmRNSTotal Voting Rights
15th Aug 20198:28 amRNSDirector/PDMR Shareholding
15th Aug 20198:26 amRNSDirector/PDMR Shareholding
14th Aug 201911:08 amRNSDirector/PDMR Shareholding
5th Aug 20197:35 amRNSTotal Voting Rights
2nd Aug 20197:00 amRNSResults for the Half Year Ended 30 June 2019
19th Jul 201910:56 amRNSInvitation to Half Year 2019 Results Presentation
1st Jul 20199:45 amRNSTotal Voting Rights
1st Jul 20197:00 amRNSCompletion of Divestment of Speciality Tapes
27th Jun 20197:00 amRNSAcquisition of Innovative Components
20th Jun 20197:00 amRNSDivestment of Speciality Tapes business
11th Jun 20197:00 amRNSDivestment of Extrusion business
6th Jun 201911:54 amRNSDirector/PDMR Shareholding
3rd Jun 201912:22 pmRNSTotal Voting Rights
3rd Jun 201912:21 pmRNSDirector Declaration
24th May 20197:02 amRNS2019 AGM Results
23rd May 20197:00 amRNSAnnual General Meeting - Trading Update
8th May 20192:12 pmRNSDirector/PDMR Shareholding
7th May 201910:53 amRNSDirector/PDMR Shareholding
1st May 20194:20 pmRNSTotal Voting Rights
12th Apr 20191:40 pmRNSDirector/PDMR Shareholding
12th Apr 201912:20 pmRNSDirector/PDMR Shareholding
8th Apr 20199:54 amRNS2019 Annual General Meeting and Trading Update
3rd Apr 20198:25 amRNSAnnual Report 2018 & 2019 AGM Notice
2nd Apr 20199:45 amRNSDirector/PDMR Shareholding
2nd Apr 20199:44 amRNSDirector/PDMR Shareholding
2nd Apr 20199:43 amRNSDirector/PDMR Shareholding
2nd Apr 20199:42 amRNSDirector/PDMR Shareholding
2nd Apr 20199:42 amRNSDirector/PDMR Shareholding
2nd Apr 20199:41 amRNSDirector/PDMR Shareholding
2nd Apr 20199:35 amRNSDirector/PDMR Shareholding
2nd Apr 20199:33 amRNSDirector/PDMR Shareholding
1st Apr 20194:05 pmRNSTotal Voting Rights
19th Mar 20197:00 amRNSAcquisition of Minority Stake in Filters Division
1st Mar 201910:10 amRNSTotal Voting Rights
1st Mar 20197:05 amRNSAppointment of Non-Executive Director
1st Mar 20197:00 amRNSFinal Results
19th Feb 201911:33 amRNSInvitation to FY 2018 Results Presentation
1st Feb 201910:04 amRNSTotal Voting Rights
14th Jan 20192:44 pmRNSDisposal of Pipe Protection Technologies Business
2nd Jan 20191:49 pmRNSTotal Voting Rights
3rd Dec 201810:27 amRNSTotal Voting Rights
16th Nov 201812:45 pmRNSDirectorate Change
15th Nov 20189:15 amRNSDirectorate Change
2nd Nov 201810:07 amRNSDirector/PDMR Shareholding
29th Oct 201812:35 pmRNSDirector/PDMR Shareholding
24th Oct 20189:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.